The relationship between psychoactive substance use and brain health has been the subject of intense debate over the last few decades. Regarding hallucinogens like ayahuasca, public perception often oscillates between unfounded fear and uncritical idealization. Psychonautic science is dedicated to unraveling this complexity through rigorous methodologies, moving away from both the dogma that “anything that touches the brain is harmful” and unsubstantiated claims.
In brief
- Longitudinal evidence: A pioneering study, replicated after one year, has detected no neuropsychological impairment in frequent ayahuasca users.
- Neurochemical mechanisms: Activation of 5-HT2A receptors releases glutamate, but the risk of neuronal toxicity depends on context and frequency, not just chemical binding.
- Importance of control: Ritual use in safe settings (such as churches in Brazil) presents a different safety profile than isolated or unprepared recreational use.
- Individual vulnerability: People with a predisposition to psychotic disorders should avoid consumption, regardless of the substance type.
- Methodological critique: Replication of studies is uncommon in traditional drug research due to costs and dogma, but it is essential for validating positive results.
The challenge of studying lasting effects
Evaluating the real impact of hallucinogen use requires overcoming significant methodological barriers. Historically, research in this field has been conditioned by a paradigm that assumes, without question, that any brain damage is a result of illegal substance use. This bias has led to the uncritical acceptance of studies with negative results without sufficiently examining their methodology.
A prominent study, funded by ICEERS and led by researchers such as Jose Carlos Bouso, addresses this issue directly. The research is titled “Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study.” Its relevance lies in two key factors:
- Sample size: 127 habitual users were evaluated and compared with 115 controls matched by age, sex, and educational level.
- Temporal replication: Unlike many studies limited to a single measurement, this work repeated the evaluations one year later to verify the stability of the results and rule out transient methodological errors.
Neurobiological mechanisms: 5-HT2A and glutamate
To understand the potential risk or benefit, it is necessary to understand what happens at the cellular level. Classic hallucinogens, including the DMT present in ayahuasca, act by selectively binding to serotonin 5-HT2A receptors in the cerebral cortex.
This binding triggers a cascade of events that produces the characteristic visual and cognitive experiences (florid effects). However, the biochemical process has a critical component: the massive release of glutamate. Glutamate is the brain’s primary excitatory neurotransmitter; in normal concentrations, it is essential for functions such as learning and memory.
The problem arises when glutamate levels rise excessively or for prolonged periods without adequate regulation, which can lead to excitotoxicity. In extreme conditions, this could theoretically cause neuronal death. Therefore, the central scientific question is: does repeated use in ritual contexts cause this imbalance?
Results of the longitudinal study
The data obtained after the one-year follow-up offer a clear and nuanced answer. Ayahuasca users who consumed the substance with a minimum frequency of twice per week for at least 15 years showed no significant differences in their neuropsychological tests compared to the controls.
This includes:
- General cognition: Attention, memory, and executive functions remained stable.
- Psychiatric symptoms: There was no evidence of increased psychopathology or long-term emotional deterioration derived from ritual use.
These findings contrast with the generalized dogma that automatically suggests brain damage. It is important to highlight that these results do not imply that ayahuasca is harmless in all circumstances, but rather that in the specific context of ritual use and under certain safety conditions, the risk of chronic neurotoxicity appears to be minimal.
Harm reduction: Context is key
Although the data are encouraging for the ritual user, science demands caution. The context of use drastically modifies the safety profile:
1. Purity and substance mixtures
In traditional churches in Brazil (such as Santo Daime or União do Vegetal), a specific preparation is used that includes DMT and harmine, a serotonin reuptake inhibitor that enhances the effects and allows for lower doses. However, consumption outside of this ritual framework often involves unpredictable mixtures with other substances (such as MDMA or cannabis) that can alter pharmacokinetics and increase risks.
2. Prior mental state
The individual’s psychological state before ingestion is crucial. People with a history of psychotic disorders, untreated severe depression, or a predisposition to manic episodes should avoid consumption. Hallucinogens can precipitate outbreaks in vulnerable individuals.
3. Frequency and dose
Although the study mentioned frequent use (twice per week), this occurs within a cultural structure that regulates the intensity and intention of the consumption. Sporadic or compulsive use without subsequent integration may have different effects than ritualized use.
Critical reading: Myths versus reality
It is common to find categorical statements in forums and social media that simplify scientific reality:
- Myth: “All illegal drugs destroy the brain.”
Reality: MDMA (illegal) and paroxetine (legal, an SSRI) share mechanisms of action on serotonin, but their risk profiles differ based on dose, purity, and legal context. - Myth: “Studies confirm it is safe.”
Reality: A study confirms the absence of damage under controlled conditions; it does not guarantee absolute safety for any user in any circumstance.
Criticizing a study without reading its methodology or context is usually counterproductive. Science progresses through scrutiny, but it also requires recognizing when data contradicts preconceived beliefs. In this case, the evidence suggests that not all hallucinogens are neurotoxic by definition.
Conclusion: Toward responsible psychonautics
Research into the long-term effects of ayahuasca and other hallucinogens is evolving. Rigorous longitudinal studies, such as the one described above, provide tools to separate myth from fact. It appears that, in controlled ritual contexts and with psychologically stable users, there is no solid evidence of chronic brain damage.
Nevertheless, caution is mandatory. The absence of neurotoxicity does not equate to total harmlessness; other effects (psychological, social) must be considered. Psychonautics invites a balanced approach: valuing the potential benefits of ritual use for mental health and personal growth, but always under the principle of harm reduction. This implies knowing the substance, respecting doses, ensuring a safe environment, and seeking professional support if difficulties arise.
Scientific truth is neither static nor dogmatic; it requires constant updating and openness to new data. In the meantime, the prudent recommendation remains: stay informed, assess individual risk, and always prioritize neuropsychological health over any cultural or ideological trend.
